BDR Pharma unveils prostate cancer drug enzalutamide at Rs 24480 per pack in India Ruchika Sharma22 Sept 2020 11:30 AM ISTThe 80 mg version is an attempt to reduce the pill burden as it is expected to increase the patient compliance, it added.
Darolutamide improves survival in nonmetastatic prostate cancer patients: NEJM Medha Baranwal12 Sept 2020 9:30 AM ISTDelhi: The administration of Darolutamide in men with nonmetastatic, castration-resistant prostate cancer led to a significantly higher rate...
New minimally invasive, safe treatment improves recovery time in prostate cancer Dr. Kamal Kant Kohli8 Sept 2020 10:48 AM ISTLOS ANGELES -- In some prostate cancer patients, radical treatment including surgery or radiation may cause side effects like urinary incontinence or...
New Study reveals link between central adiposity and fatal prostate cancer Hina Zahid3 Sept 2020 8:24 PM ISTA study of more than 200,000 UK men has linked central adiposity with fatal prostate cancer. The study is being presented at this year's European and...
Study links central adiposity in men with fatal prostate cancer Dr. Kamal Kant Kohli3 Sept 2020 10:45 AM ISTResearchers in a study of more than 200,000 UK men have revealed that there is a strong link between central adiposity (concentration of body fat...
Infertile men have higher PSA compared to fertile ones, says study Dr Satabdi Saha2 Sept 2020 10:30 AM ISTInfertile men are at greater risk for oncological and nononcological chronic disease than fertile individuals. Researchers have found in a new study...
Lower risk of COVID 19 in prostate cancer patients treated with hormone therapy: study Dr Satabdi Saha21 Aug 2020 6:00 PM ISTMen whose prostate cancer was treated with androgen-deprivation therapy (ADT) had a significantly lower risk of COVID-19 infection, according to a...
AstraZeneca Pharma gets DCGI nod to import, market prostate cancer drug Olaparib Film-coated tablets Ruchika Sharma21 Aug 2020 11:14 AM ISTMumbai: Pharma major, AstraZeneca Pharma India Limited said that it has received Import and Market permission in Form CT-20 (Marketing...
Enzalutamide may improve survival in high risk Castration-resistant prostate cancer Hina Zahid21 Aug 2020 9:30 AM ISTIn 2018 and 2019, the German Institute for Quality and Efficiency in Health Care (IQWiG) already investigated whether the drug enzalutamide has an...
Rucaparib new treatment option for some men with advanced prostate cancer Hina Zahid17 Aug 2020 9:15 AM ISTResults from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be treated...
Prostate cancer: Nerve-sparing prostatectomy increases risk of positive surgical margins: Study Medha Baranwal14 Aug 2020 1:30 PM ISTNetherland: Nerve-sparing may increase the risk of ipsilateral positive surgical margins, finds a recent study in the Journal of Urology....
Testosterone therapy not linked to recurrence of prostate cancer after treatment: Study Medha Baranwal7 Aug 2020 9:34 PM ISTUSA: Testosterone therapy(TT) is safe after definitive treatment of localized prostate cancer in appropriate patients, suggests a recent...
